IBEX Technologies Inc.

TSXV:IBT 주식 보고서

시가총액: CA$35.3m

IBEX Technologies 과거 수익 실적

과거 기준 확인 5/6

IBEX Technologies은 연평균 58%의 비율로 수입이 증가해 온 반면, Biotechs 산업은 수입이 증가했으며, 연간 22.1%였습니다. 매출은 연평균 14.1%의 비율로 증가했습니다. IBEX Technologies의 자기자본이익률은 27.9%이고 순이익률은 49.7%입니다.

주요 정보

58.0%

수익 성장률

57.1%

EPS 성장률

Biotechs 산업 성장51.1%
매출 성장률14.1%
자기자본 수익률27.9%
순이익49.7%
최근 수익 업데이트31 Jan 2024

최근 과거 실적 업데이트

IBEX Technologies' (CVE:IBT) Earnings Might Not Be As Promising As They Seem

Dec 22
IBEX Technologies' (CVE:IBT) Earnings Might Not Be As Promising As They Seem

Recent updates

The Market Lifts IBEX Technologies Inc. (CVE:IBT) Shares 27% But It Can Do More

Feb 13
The Market Lifts IBEX Technologies Inc. (CVE:IBT) Shares 27% But It Can Do More

IBEX Technologies' (CVE:IBT) Earnings Might Not Be As Promising As They Seem

Dec 22
IBEX Technologies' (CVE:IBT) Earnings Might Not Be As Promising As They Seem

Market Might Still Lack Some Conviction On IBEX Technologies Inc. (CVE:IBT) Even After 28% Share Price Boost

Dec 19
Market Might Still Lack Some Conviction On IBEX Technologies Inc. (CVE:IBT) Even After 28% Share Price Boost

Calculating The Fair Value Of IBEX Technologies Inc. (CVE:IBT)

Oct 05
Calculating The Fair Value Of IBEX Technologies Inc. (CVE:IBT)

A Look At The Fair Value Of IBEX Technologies Inc. (CVE:IBT)

May 22
A Look At The Fair Value Of IBEX Technologies Inc. (CVE:IBT)

Shareholders May Be More Conservative With IBEX Technologies Inc.'s (CVE:IBT) CEO Compensation For Now

Jan 19
Shareholders May Be More Conservative With IBEX Technologies Inc.'s (CVE:IBT) CEO Compensation For Now

We Think Shareholders Will Probably Be Generous With IBEX Technologies Inc.'s (CVE:IBT) CEO Compensation

Feb 10
We Think Shareholders Will Probably Be Generous With IBEX Technologies Inc.'s (CVE:IBT) CEO Compensation

Investors Shouldn't Be Too Comfortable With IBEX Technologies' (CVE:IBT) Robust Earnings

Mar 25
Investors Shouldn't Be Too Comfortable With IBEX Technologies' (CVE:IBT) Robust Earnings

IBEX Technologies Inc.'s (CVE:IBT) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Feb 22
IBEX Technologies Inc.'s (CVE:IBT) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

How Should Investors React To IBEX Technologies' (CVE:IBT) CEO Pay?

Dec 29
How Should Investors React To IBEX Technologies' (CVE:IBT) CEO Pay?

수익 및 비용 분석

IBEX Technologies 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

TSXV:IBT 수익, 비용 및 수입 (CAD Millions )
날짜수익수익G+A 비용R&D 비용
31 Jan 248441
31 Oct 238431
31 Jul 237431
30 Apr 238231
31 Jan 238131
31 Oct 228230
31 Jul 228230
30 Apr 227230
31 Jan 226120
31 Oct 216120
31 Jul 215120
30 Apr 215120
31 Jan 216120
31 Oct 205120
31 Jul 205120
30 Apr 205020
31 Jan 204-120
31 Oct 194-120
31 Jul 194-120
30 Apr 194-120
31 Jan 195020
31 Oct 185020
31 Jul 185020
30 Apr 185220
31 Jan 185220
31 Oct 175320
31 Jul 175320
30 Apr 175120
31 Jan 174020
31 Oct 164020
31 Jul 164020
30 Apr 165120
31 Jan 165120
31 Oct 154120
31 Jul 153020
30 Apr 153-120
31 Jan 153-120
31 Oct 144020
31 Jul 144020
30 Apr 144020
31 Jan 144020
31 Oct 134020
31 Jul 134020
30 Apr 134-120

양질의 수익: IBT 의 비현금 수입 수준이 높습니다.

이익 마진 증가: IBT 의 현재 순이익 이익률 (49.7%) 작년보다 높습니다 (17.8%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: IBT 의 수익은 지난 5년 동안 매년 58% 씩 크게 증가했습니다.

성장 가속화: 지난 1년간 IBT 의 수익 증가율( 187.4% )은 연간 평균( 58% 초과합니다. ).

수익 대 산업: 지난 1년간 IBT 수익 증가율( 187.4% )은 Biotechs 업계 16.6% 초과했습니다.


자기자본 수익률

높은 ROE: IBT 의 자본 수익률( 27.9% )은 높음으로 간주됩니다.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기